| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 71.70B | 73.77B | 71.20B | 71.67B | 69.79B | 59.44B |
| Gross Profit | 14.97B | 16.01B | 14.76B | 15.04B | 14.43B | 14.73B |
| EBITDA | 3.30B | 4.21B | 3.15B | 3.52B | 1.42B | 1.79B |
| Net Income | 28.00M | -2.85B | -29.00M | 3.22B | -1.10B | 388.00M |
Balance Sheet | ||||||
| Total Assets | 88.43B | 81.55B | 88.71B | 96.12B | 92.98B | 88.85B |
| Cash, Cash Equivalents and Short-Term Investments | 7.12B | 5.62B | 8.74B | 13.42B | 6.95B | 6.60B |
| Total Debt | 24.30B | 23.47B | 24.52B | 25.33B | 26.60B | 24.28B |
| Total Liabilities | 46.93B | 44.43B | 46.92B | 53.30B | 53.45B | 47.05B |
| Stockholders Equity | 44.15B | 41.85B | 44.25B | 44.52B | 40.61B | 42.18B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -1.10B | -4.21B | 8.43B | -1.67B | -9.95B |
| Operating Cash Flow | 0.00 | 1.23B | -2.31B | 9.95B | 263.00M | 1.21B |
| Investing Cash Flow | 0.00 | -1.99B | -2.15B | -1.77B | -662.00M | -9.56B |
| Financing Cash Flow | 0.00 | -1.50B | -1.23B | -1.70B | 915.00M | 6.80B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥188.62B | 12.60 | ― | 3.41% | 3.85% | 42.23% | |
73 Outperform | ¥32.01B | 9.06 | ― | 3.56% | 3.46% | 102.90% | |
73 Outperform | ¥167.70B | 11.62 | ― | 4.91% | 3.03% | 16.46% | |
65 Neutral | ¥7.93B | 4.20 | ― | 1.66% | 16.91% | 1710.26% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
49 Neutral | ¥10.78B | -3.79 | ― | 4.41% | 3.61% | -9713.46% | |
43 Neutral | ¥8.01B | -5.48 | ― | 2.65% | 1.29% | -181.94% |